Q. Ping Dou

25.0k citations

269 papers · 17.8k · 3 hit papers · h-index 74

Impact in

Applied Microbiology and Biotechnology top 0.1%
Oncology top 0.2%
- Metal complexes synthesis and properties
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis

Papers in

Molecular Biology 164
- Ubiquitin and proteasome pathways 98
- Cell death mechanisms and regulation 32
Oncology 113
- Cancer-related Molecular Pathways 50
- Metal complexes synthesis and properties 38
- Peptidase Inhibition and Analysis 23

Co-authors: Huanjie Yang (34 shared papers)Di Chen (21 shared papers)Qiuzhi Cindy Cui (26 shared papers)Vesna Milacic (17 shared papers)Sara M. Schmitt (19 shared papers)Kristin R. Landis‐Piwowar (24 shared papers)Michael Frezza (15 shared papers)Tak Hang Chan (33 shared papers)
Journals: Journal of Cellular Biochemistry (17 papers)International Journal of Molecular Medicine (13 papers)Cancer Research (12 papers)PLoS ONE (8 papers)Bioorganic & Medicinal Chemistry (7 papers)
Partner nations: United States China Hong Kong

In The Last Decade

Q. Ping Dou

269 papers receiving 17.5k citations

Q. Ping Dou's Hit Papers

align trajectories log scale

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives 2011 · 646 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Current Cancer Drug Targets
2010 Current Pharmaceutical Design
2006 Cancer Research

Peers

Countries citing papers authored by Q. Ping Dou

Since Specialization

Citations

This map shows the geographic impact of Q. Ping Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Ping Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Ping Dou more than expected).

Fields of papers citing papers by Q. Ping Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Ping Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Ping Dou. The network helps show where Q. Ping Dou may publish in the future.

Co-authors

The 25 scholars most cited alongside Q. Ping Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Q. Ping Dou Line = papers co-authored together Q. Ping Dou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives Current Cancer Drug Targets ·D. Chen, Michael Frezza, Sara M. Schmitt, Jyoti Kanwar, Q. Ping Dou Hit paper breakdown →	2011	646
2	Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity Cancer Research ·Di Chen, Qiuzhi Cindy Cui, Huanjie Yang, Q. Ping Dou Hit paper breakdown →	2006	579
3	Celastrol, a Triterpene Extracted from the Chinese “Thunder of God Vine,” Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice Cancer Research ·Huanjie Yang, Di Chen, Qiuzhi Cindy Cui, Xiao Yuan, Q. Ping Dou	2006	499
4	Novel Metals and Metal Complexes as Platforms for Cancer Therapy Current Pharmaceutical Design ·Michael Frezza, S.S. Hindo, Di Chen, Andrew M. Davenport, Sara M. Schmitt, Dajena Tomco, Q. Ping Dou Hit paper breakdown →	2010	468
5	Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo Journal of Biological Chemistry ·Sangkil Nam, David M. Smith, Q. Ping Dou	2001	425
6	Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression Proceedings of the National Academy of Sciences ·Benyi Li, Q. Ping Dou	2000	388
7	Novel Schiff Base Copper Complexes of Quinoline-2 Carboxaldehyde as Proteasome Inhibitors in Human Prostate Cancer Cells Journal of Medicinal Chemistry ·Shreelekha Adsule, Vivek Barve, Di Chen, Fakhara Ahmed, Q. Ping Dou, Subhash Padhyé, Fazlul H. Sarkar	2006	297
8	Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts Cell Death and Differentiation ·Bing An, Ronald H. Goldfarb, Robert Siman, Q. Ping Dou	1998	288
9	Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Research ·Kenyon G. Daniel, Di Chen, Shirley Orlu, Qiuzhi Cindy Cui, Fred R. Miller, Q. Ping Dou	2005	286
10	A Novel Anticancer Gold(III) Dithiocarbamate Compound Inhibits the Activity of a Purified 20S Proteasome and 26S Proteasome in Human Breast Cancer Cell Cultures and Xenografts Cancer Research ·Vesna Milacic, Di Chen, Luca Ronconi, Kristin R. Landis‐Piwowar, Dolores Fregona, Q. Ping Dou	2006	280
11	Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells Biochemical Pharmacology ·Di Chen, Kenyon G. Daniel, Marina S. Chen, Deborah J. Kuhn, Kristin R. Landis‐Piwowar, Q. Ping Dou	2005	269
12	N-terminal cleavage of Bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes Bcl-2-independent cytochrome C release and apoptotic cell death Journal of Cellular Biochemistry ·Gui Gao, Q. Ping Dou	2000	268
13	Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells Biochemical Pharmacology ·Kenyon G. Daniel, Puja Gupta, R.Hope Harbach, Wayne C. Guida, Q. Ping Dou	2003	263
14	Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance Journal of Controlled Release ·Ayman Khdair, Di Chen, Yogesh Patil, Linan Ma, Q. Ping Dou, Malathy P.V. Shekhar, Jayanth Panyam	2009	229
15	Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System Current Cancer Drug Targets ·Q. Ping Dou, Jeffrey A. Zonder	2014	226
16	Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo Cancer Research ·Vesna Milacic, Sanjeev Banerjee, Kristin R. Landis‐Piwowar, Fazlul H. Sarkar, Adhip P.N. Majumdar, Q. Ping Dou	2008	217
17	Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts Cancer Research ·Di Chen, Qiuzhi Cindy Cui, Huanjie Yang, Raúl A. Barrea, Fazlul H. Sarkar, Shijie Sheng, Bing Yan, G. Prem Veer Reddy, Q. Ping Dou	2007	190
18	A Novel Prodrug of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate as a Potential Anticancer Agent Cancer Research ·Kristin R. Landis‐Piwowar, Congde Huo, Di Chen, Vesna Milacic, Guoqing Shi, Tak Hang Chan, Q. Ping Dou	2007	187
19	Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells Journal of Medicinal Chemistry ·Boris Cvek, Vesna Milacic, Jan Taraba, Q. Ping Dou	2008	184
20	Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. PubMed ·B An, Q. Ping Dou	1996	184

About Q. Ping Dou

Q. Ping Dou is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Applied Microbiology and Biotechnology, having authored 269 papers that have together received 17.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (98 papers), Cancer-related Molecular Pathways (50 papers), Tea Polyphenols and Effects (43 papers), Metal complexes synthesis and properties (38 papers), Cell death mechanisms and regulation (32 papers), Tannin, Tannase and Anticancer Activities (24 papers), Peptidase Inhibition and Analysis (23 papers) and Trace Elements in Health (16 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (689 citations), Oncology (5.8k citations), Toxicology (578 citations), Biochemistry (978 citations) and Pathology and Forensic Medicine (2.3k citations). Q. Ping Dou has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Huanjie Yang, Di Chen, Qiuzhi Cindy Cui, Vesna Milacic, Sara M. Schmitt, Kristin R. Landis‐Piwowar, Michael Frezza, Tak Hang Chan, David M. Smith and Benyi Li. Their work appears in journals such as Journal of Cellular Biochemistry, International Journal of Molecular Medicine, Cancer Research, PLoS ONE and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Q. Ping Dou

Impact in

Papers in i

In The Last Decade

Q. Ping Dou

Q. Ping Dou's Hit Papers

Peers

Countries citing papers authored by Q. Ping Dou

Fields of papers citing papers by Q. Ping Dou

All Works

About Q. Ping Dou

Explore authors with similar magnitude of impact

Papers in